Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

“Fructo-oligosaccharides (FOS) are prebiotic fibers that have a significant impact on the secretion and function of the ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

While HA is known for its roles in tissue structure and inflammation ... fine-tunes glucose metabolism beyond the classic insulin-glucagon system. With diabetes affecting millions worldwide ...

A recent study published in Life Metabolism has uncovered a surprising new player in the body's ability to regulate blood sugar after eating.

Collaboration combines Novo Nordisk's scientific leadership in obesity and cardiometabolic diseases with Septerna's expertise in G protein-coupled receptor (GPCR) drug discovery Goal is to develop ...